Biological Evaluation and In Silico Study of Benzoic Acid Derivatives from <i>Bjerkandera adusta</i> Targeting Proteostasis Network Modules
Katerina Georgousaki,
Nikolaos Tsafantakis,
Sentiljana Gumeni,
George Lambrinidis,
Victor González-Menéndez,
Jose R. Tormo,
Olga Genilloud,
Ioannis P. Trougakos,
Nikolas Fokialakis
Affiliations
Katerina Georgousaki
Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 157 71 Athens, Greece
Nikolaos Tsafantakis
Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 157 71 Athens, Greece
Sentiljana Gumeni
Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, 157 72 Athens, Greece
George Lambrinidis
Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 157 84 Athens, Greece
Victor González-Menéndez
Fundacion MEDINA, Health Sciences Technology Park, 18016 Granada, Spain
Jose R. Tormo
Fundacion MEDINA, Health Sciences Technology Park, 18016 Granada, Spain
Olga Genilloud
Fundacion MEDINA, Health Sciences Technology Park, 18016 Granada, Spain
Ioannis P. Trougakos
Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, 157 72 Athens, Greece
Nikolas Fokialakis
Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 157 71 Athens, Greece
A main cellular functional module that becomes dysfunctional during aging is the proteostasis network. In the present study, we show that benzoic acid derivatives isolated from Bjerkandera adusta promote the activity of the two main protein degradation systems, namely the ubiquitin-proteasome (UPP) and especially the autophagy-lysosome pathway (ALP) in human foreskin fibroblasts. Our findings were further supported by in silico studies, where all compounds were found to be putative binders of both cathepsins B and L. Among them, compound 3 (3-chloro-4-methoxybenzoic acid) showed the most potent interaction with both enzymes, which justifies the strong activation of cathepsins B and L (467.3 ± 3.9%) on cell-based assays. Considering that the activity of both the UPP and ALP pathways decreases with aging, our results suggest that the hydroxybenzoic acid scaffold could be considered as a promising candidate for the development of novel modulators of the proteostasis network, and likely of anti-aging agents.